UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
_____________________________________
FORM 8-K
CURRENT REPORT
Pursuant
to Section 13 or 15(d) of the Securities Exchange Act of
1934
Date of
Report (Date of earliest event reported): May 13, 2021
__________________________________________
Dynatronics Corporation
(Exact
name of registrant as specified in its charter)
__________________________________________
Utah
|
|
0-12697
|
|
87-0398434
|
(State
or other jurisdiction of incorporation)
|
|
Commission
File Number
|
|
(IRS
Employer Identification Number)
|
1200 Trapp Rd, Eagan, Minnesota
|
|
55121
|
(Address
of principal executive offices)
|
|
(Zip
Code)
|
(801) 568-7000
|
|
|
(Registrant's
telephone number, including area code)
|
|
|
Check
the appropriate box below if the Form 8-K filing is intended to
simultaneously satisfy the filing obligation of the registrant
under any of the following provisions:
☐ Written
communications pursuant to Rule 425 under the Securities Act (17
CFR 230.425)
☐ Soliciting
material pursuant to Rule 14a-12 under the Exchange Act (17 CFR
240.14a-12)
☐ Pre-commencement communications
pursuant to Rule 14(d)-2(b) under the Exchange Act (17 CFR
240.14d-2(b))
☐ Pre-commencement communications
pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR
240.13e-4(c))
Securities
registered pursuant to Section 12(b) of the Act:
Title of each class
|
|
Trading Symbol(s)
|
|
Name of each exchange on which registered
|
Common
stock, no par value
|
|
DYNT
|
|
The
Nasdaq Capital Market
|
Indicate
by check mark whether the registrant is an emerging growth company
as defined in Rule 405 of the Securities Act of 1933 (§230.405
of this chapter) or Rule 12b-2 of the Securities Exchange Act of
1934 (§240.12b-2 of this chapter).
Emerging
growth company ☐
If an
emerging growth company, indicate by check mark if the registrant
has elected not to use the extended transition period for complying
with any new or revised financial accounting standards provided
pursuant to Section 13(a) of the Exchange Act. ☐
Item
1.01
Enter
into a Material Definitive Agreement
On May
13, 2021, Dynatronics Corporation (“Dynatronics”) and
Maple Leaf Realco VII, LLC closed on the Purchase and Sale
Agreement (the “Agreement”) for the sale of
Dynatronics’ former manufacturing facility building located
at 6607 Mountainview Road, Ooltewah, Tennessee for a purchase price
of $1.75 million USD. Net proceeds are estimated to be $1.65
million.
On May
17, 2021, Dynatronics issued a press release announcing the
Agreement. A copy of this press release is filed as Exhibit 99.1 to
this Report on Form 8-K and is incorporated into this Item 8.01 by
reference.
Item
9.01
Financial
Statements and Exhibits
|
|
|
Exhibit Number
|
|
Description
|
|
|
Press
Release dated May 17, 2021
|
SIGNATURE
Pursuant
to the requirements of the Securities Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf
by the undersigned hereunto duly authorized.
Date:
May 17, 2021
|
DYNATRONICS CORPORATION
|
|
|
|
|
|
|
By:
|
/s/John
Krier
|
|
|
Name: John
Krier
|
|
Title:
|
Chief
Executive Officer
|
|
Dynatronics Corporation Announces Closing
of Transaction to Sell Tennessee Facility
EAGAN, MN / ACCESSWIRE / May 17,
2021 / Dynatronics
Corporation (NASDAQ:DYNT),
a leading manufacturer of athletic training, physical therapy, and
rehabilitation products, announced today that it has closed on its
purchase and sale agreement with Maple Leaf Realco VII, LLC for a
purchase price of $1.75 million USD, effective May 13, 2021.
Net
proceeds to Dynatronics for the sale are approximately $1.65
million.
As previously
announced, the company closed its facility consisting of 54,000
square feet of manufacturing space in Ooltewah, Tennessee in the
second quarter of fiscal year 2021 as part of consolidation and
cost reduction initiatives. Products formerly manufactured in
Tennessee are now being produced in the company’s New Jersey
and Minnesota locations.
John Krier,
President and Chief Executive Officer of Dynatronics commented,
“Closing on this transaction is another step that we have
taken to reduce our cost structure, add additional liquidity to
capitalize on M&A or innovation partnerships and focus on
generating a sustainably profitable financial model for our
shareholders. The sale of the facility is a win-win for us, as it
adds cash to the balance sheet while simultaneously reducing our
operating expenses, and makes us a more efficient
manufacturer.”
About
Dynatronics Corporation
Dynatronics
Corporation is a leading medical device company committed to
providing high-quality restorative products designed to accelerate
achieving optimal health. The company designs, manufactures, and
sells a broad range of products for clinical use in physical
therapy, rehabilitation, pain management, and athletic training.
Through its distribution channels, Dynatronics markets and sells to
orthopedists, physical therapists, chiropractors, athletic
trainers, sports medicine practitioners, clinics, hospitals, and
consumers. The company’s products are marketed under a
portfolio of high-quality, well-known industry brands including
Bird & Cronin®, Dynatron
Solaris®, Hausmann™,
Physician’s Choice®, and
PROTEAM™, among others. More information is available at
www.dynatronics.com.
Investor Contacts:
Dynatronics
Corporation
Investor
Relations
Skyler
Black
(801)
676-7201
ir@dynatronics.com
Darrow
Associates
Peter
Seltzberg, Managing Director
(516)
419-9915
pseltzberg@darrowir.com
For additional information, please
visit: www.dynatronics.com.
Connect with Dynatronics
on LinkedIn.
SOURCE: Dynatronics Corporation